Dry Eye Syndrome Treatment Market to be dominated by Cyclosporine Type through 2028
The growing prevalence of dry eye
syndrome is expected to drive the growth of the global dry eye syndrome
treatment market in the forecast period,2024-2028.
According to TechSci Research report,
“Dry Eye Syndrome Treatment Market - Global Industry Size, Share, Trends,
Opportunity, and Forecast, 2018-2028”, the global dry eye syndrome treatment
market is anticipated to grow at an impressive rate in the forecast period,
2024-2028. This can be ascribed to the increasing prevalence of dry eye
diseases along with the growing adoption of different treatments like dry eye
treatment drops and artificial tears for relieving different symptoms across
the globe. Similarly, the growing popularity of excimer and femtosecond
ophthalmic laser treatment for dry eye syndrome will further boost the market
growth over the years. Also, growing awareness regarding the diagnosis and
treatment of dry eye disease such as laser treatment among populations across
the globe will further propel the market growth. Additionally, growing demand
for better treatment outcomes and an increase in living standards especially in
the developed countries in North America and Europe is expected to create
lucrative opportunities for market growth in coming years. Besides, increasing
research and development activities in dry eye disease is further expected to
support the market growth. Similarly,
rising the number of eye care centers across the globe and rising penetration
of OTC eyedrop in the developing region will drive the market growth over the
years.
However, due to lack of awareness
regarding dry eye disease and their treatment, people do not visit
ophthalmologists regularly unless there is any symptomatic condition. This can
slow down the growth of global dry eye syndrome treatment market in the
forecast period. Similarly, high risks and complications associated with dry
eye treatment may hamper the dry eye syndrome treatment market growth during
the forecast period. Also, poor reimbursement scenario and lack of insurance
coverage for dry eye disease in emerging countries can further restrict the
growth of global dry eye syndrome treatment market.
Browse over XX market data Figures
spread through XX
Pages and an in-depth TOC on "Dry Eye Syndrome Treatment Market"
The global dry eye
syndrome treatment market
can be segmented by indication, product type, dosage form, type, distribution
channel and by region.
Based on product type, the global dry eye
syndrome treatment market can be segmented into Cyclosporine,
Topical Corticosteroids, Artificial Tears, Punctal Plugs, and Others.
The cyclosporine segment dominated the market in 2022 and is expected to
continue maintaining its dominance throughout the forecast period. This can be
ascribed to the long-standing use of medications effect for dry eye disease
symptoms and used as a clinical indicator. Similarly, the easy availability of
new products such as EvoTears is expected to create significant growth during
the forecast period.
Based on dosage form, the market can be
segmented into Gels, Eye Solutions, Capsules & Tablets, Eye Drops, and
Ointments. The eye drops segment is expected to dominate during the forecast
period on account of increasing usage and administration which leads to patient
compliance with the treatment.
Similarly, the launch of products and investments by major players also
drive market growth over the years.
Major companies operating in the global
dry eye syndrome treatment market are:
- Johnson & Johnson
- AbbVie Inc.
- Bausch Health Companies Inc.
- Novartis AG
- Sun Pharmaceuticals Industries
Limited
- Santen Pharmaceutical Co.,
Ltd.
- Otsuka Pharmaceutical Co.,
Ltd.
- Oyster Point Pharma, Inc.
- Alcon Inc.
- GlaxoSmithKline plc.
For instance, in April 2021, Alcon announced the
launch of its Systane eye drops with hydroboost technology for providing
long-lasting relief to patients that apply eye drops over 4 times a day.
For instance, in December 2021, NTC Srl and I-MED
announced a partnership for making 0.4% sodium hyaluronate ointment available
in the U.S. market.
Download Free Sample Report
Customers can also request
for 10% free customization on this report.
“North America is
expected to dominate in the global dry eye syndrome treatment market on account
due to the increasing geriatric population are susceptible to different types
of eye diseases, increasing development of better healthcare for the treatment
of dry eye diseases, and rising adoption of new treatment across the region.
Furthermore, the increasing prevalence of dry eye disease and easy access to
healthcare are further contributing to the demand for the dry eye syndrome
treatment market. Besides, the availability of skilled professionals and early
adoption of advanced treatments for the treatment of different dry eye diseases
in the region is further expected to create lucrative opportunities for the
market growth” said Mr. Karan Chechi, Research Director with TechSci Research,
a research based global management consulting firm.
“Dry
Eye Syndrome Treatment Market - Global Industry Size, Share, Trends,
Opportunity, and Forecast, 2018-2028, Segmented
By Indication (Evaporative Dry Eye Syndrome v/s Aqueous Deficient Dry Eye
Syndrome), By Product Type (Cyclosporine, Topical Corticosteroids, Artificial
Tears, Punctal Plugs, Others), By Dosage Form (Gels, Eye Solutions, Capsules
& Tablets, Eye Drops, Ointments), By Type (Prescription v/s Over The
Counter), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies,
Online Pharmacies),
By Region and Competition”, has evaluated
the future growth potential of global dry eye syndrome treatment market and
provides statistics & information on market size, structure, and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in global dry eye syndrome treatment market.
Contact
Mr. Ken Mathews
708
Third Avenue,
Manhattan,
NY,
New York – 10017
Tel:
+1-646-360-1656
Email: [email protected]m
Website: https://www.techsciresearch.com